• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《Odd Couple(s): 多药效团β-内酰胺类抗生素概述》

The Odd Couple(s): An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group.

机构信息

Department of Chemistry and Biology "A. Zambelli", University of Salerno, 84084 Fisciano (SA), Italy.

出版信息

Int J Mol Sci. 2021 Jan 9;22(2):617. doi: 10.3390/ijms22020617.

DOI:10.3390/ijms22020617
PMID:33435500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7826672/
Abstract

β-lactam antibiotics are among the most important and widely used antimicrobials worldwide and are comprised of a large family of compounds, obtained by chemical modifications of the common scaffolds. Usually these modifications include the addition of active groups, but less frequently, molecules were synthesized in which either two β-lactam rings were joined to create a single bifunctional compound, or the azetidinone ring was joined to another antibiotic scaffold or another molecule with a different activity, in order to create a molecule bearing two different pharmacophoric functions. In this review, we report some examples of these derivatives, highlighting their biological properties and discussing how this strategy can lead to the development of innovative antibiotics that can represent either novel weapons against the rampant increase of antimicrobial resistance, or molecules with a broader spectrum of action.

摘要

β-内酰胺类抗生素是全球最重要和应用最广泛的抗生素之一,它们由一大类化合物组成,这些化合物通过对常见支架的化学修饰而获得。通常,这些修饰包括添加活性基团,但较少见的是,合成了分子,其中要么将两个β-内酰胺环连接在一起形成单一的双功能化合物,要么将氮杂环丁酮环连接到另一个抗生素支架或另一个具有不同活性的分子上,以创建具有两个不同药效基团的分子。在这篇综述中,我们报告了这些衍生物的一些例子,强调了它们的生物学特性,并讨论了这种策略如何导致开发创新的抗生素,这些抗生素可以作为对抗抗菌药物耐药性猖獗增长的新武器,或者具有更广泛作用谱的分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/1ca0c81a1250/ijms-22-00617-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/d16f2c766ea2/ijms-22-00617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/701757c5d260/ijms-22-00617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/edd1c56d8ab7/ijms-22-00617-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/c42eeec581ab/ijms-22-00617-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/03dd0d65f5f1/ijms-22-00617-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/46331ea62065/ijms-22-00617-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/d11d18c30224/ijms-22-00617-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/adf130138ad0/ijms-22-00617-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/55b1065f4530/ijms-22-00617-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/ace4cc842427/ijms-22-00617-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/14c11ecbc916/ijms-22-00617-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/1ca0c81a1250/ijms-22-00617-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/d16f2c766ea2/ijms-22-00617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/701757c5d260/ijms-22-00617-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/edd1c56d8ab7/ijms-22-00617-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/c42eeec581ab/ijms-22-00617-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/03dd0d65f5f1/ijms-22-00617-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/46331ea62065/ijms-22-00617-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/d11d18c30224/ijms-22-00617-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/adf130138ad0/ijms-22-00617-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/55b1065f4530/ijms-22-00617-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/ace4cc842427/ijms-22-00617-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/14c11ecbc916/ijms-22-00617-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1869/7826672/1ca0c81a1250/ijms-22-00617-g012.jpg

相似文献

1
The Odd Couple(s): An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group.《Odd Couple(s): 多药效团β-内酰胺类抗生素概述》
Int J Mol Sci. 2021 Jan 9;22(2):617. doi: 10.3390/ijms22020617.
2
β-lactam antibiotics: An overview from a medicinal chemistry perspective.β-内酰胺类抗生素:从药物化学角度综述。
Eur J Med Chem. 2020 Dec 15;208:112829. doi: 10.1016/j.ejmech.2020.112829. Epub 2020 Sep 16.
3
New compounds for a good old class: Synthesis of two Β-lactam bearing cephalosporins and their evaluation with a multidisciplinary approach.新化合物为经典老药添彩:两种含β-内酰胺的头孢菌素的合成及其多学科评价。
Bioorg Med Chem. 2020 Feb 15;28(4):115302. doi: 10.1016/j.bmc.2019.115302. Epub 2020 Jan 3.
4
Novel Penicillin-Type Analogues Bearing a Variable Substituted 2-Azetidinone Ring at Position 6: Synthesis and Biological Evaluation.6位带有可变取代2-氮杂环丁酮环的新型青霉素类类似物:合成与生物学评价
Molecules. 2015 Dec 10;20(12):22044-57. doi: 10.3390/molecules201219828.
5
Overcoming resistance to β-lactam antibiotics.克服对β-内酰胺类抗生素的耐药性。
J Org Chem. 2013 May 3;78(9):4207-13. doi: 10.1021/jo400236f. Epub 2013 Mar 28.
6
Novel beta-lactam antibiotics derivatives: their new applications as gene reporters, antitumor prodrugs and enzyme inhibitors.新型β-内酰胺抗生素衍生物:它们作为基因报告分子、抗肿瘤前药和酶抑制剂的新应用。
Mini Rev Med Chem. 2008 May;8(5):455-71. doi: 10.2174/138955708784223558.
7
Beta-lactam antibiotic resistance: a current structural perspective.β-内酰胺抗生素耐药性:当前的结构视角
Curr Opin Microbiol. 2005 Oct;8(5):525-33. doi: 10.1016/j.mib.2005.08.016.
8
Synthesis and antimicrobial evaluation of novel bis-β-lactam grafted macrocycles.新型双β-内酰胺接枝大环化合物的合成与抗菌活性评价
Med Chem. 2014;10(7):730-7. doi: 10.2174/1573406410666140226115258.
9
Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?β-内酰胺抗生素的环丁酮类似物:具有未开发潜力的β-内酰胺酶抑制剂?
Chembiochem. 2017 Feb 16;18(4):338-351. doi: 10.1002/cbic.201600529. Epub 2017 Feb 7.
10
Azetidin-2-ones, synthon for biologically important compounds.氮杂环丁烷-2-酮,生物重要化合物的合成子。
Curr Med Chem. 2004 Jul;11(14):1889-920. doi: 10.2174/0929867043364874.

引用本文的文献

1
Immobilization of IMP-1 metallo-beta-lactamase on FeO@SiO as nanobiocatalyst for degradation of beta-lactam antibiotics in wastewater.将IMP-1金属β-内酰胺酶固定在FeO@SiO上作为纳米生物催化剂用于降解废水中的β-内酰胺抗生素。
Water Sci Technol. 2022 Apr;85(7):2189-2207. doi: 10.2166/wst.2022.098. Epub 2022 Mar 22.
2
Arthrospira maxima and biosynthesized zinc oxide nanoparticles as antibacterials against carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii: a review article.最大螺旋藻和生物合成氧化锌纳米粒子作为抗碳青霉烯类耐药肺炎克雷伯菌和鲍曼不动杆菌的抗菌剂:综述文章。
Microb Cell Fact. 2024 Nov 19;23(1):311. doi: 10.1186/s12934-024-02584-x.
3

本文引用的文献

1
Antimicrobial Activity of Calixarenes and Related Macrocycles.杯芳烃及相关大环的抗菌活性。
Molecules. 2020 Nov 5;25(21):5145. doi: 10.3390/molecules25215145.
2
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens.头孢地尔:一种新型的针对多重耐药革兰氏阴性病原体的铁载体头孢菌素。
Pharmacotherapy. 2020 Dec;40(12):1228-1247. doi: 10.1002/phar.2476. Epub 2020 Nov 19.
3
Recent advances in the development of β-lactamase inhibitors.β-内酰胺酶抑制剂的最新研究进展。
Synthesis of cationic -acylated thiazolidine for selective activity against Gram-positive bacteria and evaluation of -acylation's role in membrane-disrupting activity.
用于对革兰氏阳性菌具有选择性活性的阳离子酰化噻唑烷的合成及酰化在膜破坏活性中的作用评估。
RSC Med Chem. 2024 Oct 21. doi: 10.1039/d4md00626g.
4
A magnetic epitope-imprinted microsphere used for selective separation and rapid detection of SHV-type β-lactamases in bacteria: a novel strategy of antimicrobial resistance detection.一种用于选择性分离和快速检测细菌中 SHV 型β-内酰胺酶的磁性表位印迹微球:一种新的抗菌药物耐药性检测策略。
J Nanobiotechnology. 2024 Nov 5;22(1):678. doi: 10.1186/s12951-024-02949-9.
5
Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β-Lactam Antibiotics.聚阳离子肽的缀合扩展了β-内酰胺抗生素的疗效谱。
Adv Sci (Weinh). 2024 Dec;11(48):e2411406. doi: 10.1002/advs.202411406. Epub 2024 Nov 5.
6
Synergistic potential of Leu-teixobactin and cefepime against multidrug-resistant Staphylococcus aureus.Leu-teixobactin 与头孢吡肟联合应用对多重耐药金黄色葡萄球菌的协同作用。
BMC Microbiol. 2024 Oct 29;24(1):442. doi: 10.1186/s12866-024-03577-x.
7
Navigating Antibacterial Frontiers: A Panoramic Exploration of Antibacterial Landscapes, Resistance Mechanisms, and Emerging Therapeutic Strategies.探索抗菌前沿:全景式探索抗菌领域、耐药机制及新兴治疗策略。
ACS Infect Dis. 2024 May 10;10(5):1483-1519. doi: 10.1021/acsinfecdis.4c00115. Epub 2024 May 1.
8
Quantification of β-lactamase producing bacteria in German surface waters with subsequent MALDI-TOF MS-based identification and β-lactamase activity assay.对德国地表水中产β-内酰胺酶细菌进行定量分析,并随后基于基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)进行鉴定及β-内酰胺酶活性测定。
Heliyon. 2024 Mar 5;10(5):e27384. doi: 10.1016/j.heliyon.2024.e27384. eCollection 2024 Mar 15.
9
Exploring antibiotic resistance mechanisms in for enhanced therapeutic approaches.探索[具体对象]中的抗生素耐药机制以改进治疗方法。 (你提供的原文“Exploring antibiotic resistance mechanisms in for enhanced therapeutic approaches.”中“in for”之间缺少具体内容,我根据语境补充了“[具体对象]”,你可根据实际情况调整)
Front Microbiol. 2024 Feb 6;15:1331508. doi: 10.3389/fmicb.2024.1331508. eCollection 2024.
10
Treatment of MRSA Infection: Where are We?耐甲氧西林金黄色葡萄球菌感染的治疗:我们在哪里?
Curr Med Chem. 2024;31(28):4425-4460. doi: 10.2174/0109298673249381231130111352.
J Microbiol. 2020 Aug;58(8):633-647. doi: 10.1007/s12275-020-0285-z. Epub 2020 Jul 27.
4
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units.在加拿大重症监护病房中分离的革兰氏阴性杆菌的体外活性研究:新型铁载体头孢菌素头孢地尔。
Diagn Microbiol Infect Dis. 2020 May;97(1):115012. doi: 10.1016/j.diagmicrobio.2020.115012. Epub 2020 Feb 4.
5
New compounds for a good old class: Synthesis of two Β-lactam bearing cephalosporins and their evaluation with a multidisciplinary approach.新化合物为经典老药添彩:两种含β-内酰胺的头孢菌素的合成及其多学科评价。
Bioorg Med Chem. 2020 Feb 15;28(4):115302. doi: 10.1016/j.bmc.2019.115302. Epub 2020 Jan 3.
6
Antibiotics: past, present and future.抗生素:过去、现在和未来。
Curr Opin Microbiol. 2019 Oct;51:72-80. doi: 10.1016/j.mib.2019.10.008. Epub 2019 Nov 13.
7
In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria.头孢地尔罗酯对广泛临床重要革兰氏阴性菌的体外活性。
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S544-S551. doi: 10.1093/cid/ciz827.
8
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics.铁和铁载体在感染中的作用,以及铁载体抗生素的发展。
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S529-S537. doi: 10.1093/cid/ciz825.
9
Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?铁载体-抗生素缀合物设计:针对坏菌的新药?
Molecules. 2019 Sep 11;24(18):3314. doi: 10.3390/molecules24183314.
10
An overview of recent progress in siderophore-antibiotic conjugates.铁载体-抗生素缀合物的研究进展概述。
Eur J Med Chem. 2019 Nov 15;182:111615. doi: 10.1016/j.ejmech.2019.111615. Epub 2019 Aug 12.